Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer


18th International Conference on Nephrology & Urology

Osaka, Japan

Simon Allen

Simon Allen

Fine Treatment

Title: Thermobalancing therapy and Dr Allen's devices as an innovative treatment for prostate enlargement, chronic prostatitis and kidney stones


Biography: Simon Allen


Thermobalancing therapy® (TT) and Dr. Allen’s therapeutic devices (DATD) provide a side effects free treatment for common
chronic urological diseases, such as benign prostatic hyperplasia (BPH), chronic prostatitis and kidney stone disease. TT and
DATD received US patent as “Therapeutic Device and Method”. TT is based on a new understanding of the origin of diseases that
states that all chronic internal diseases have the same root, the pathological activity of capillaries. As a result of changes in small
blood vessels, the focus of hypothermia becomes a continuous trigger in the affected tissue, which gradually increases the pressure
in the affected organ that leads to its malfunction. Therapeutic device applies a natural thermoelement, which accumulates the
body heat, to the projection of the affected organ eliminating the focus of hypothermia. For prostate problems, thermoelement
must be applied to the coccyx area and to dissolve kidney stones 2 thermoelements must be applied to the projection of kidneys.
Dr. Allen’s device is a class 1 medical device, so it can be used by everyone at home. Two clinical trials on TT confirmed its
effectiveness. After six-month use of DATD in 124 men with BPH, the prostate volume (mL) decreased from 45.1 to 31.8 and
urinary symptoms score from 14.3 to 4.7. In men with chronic prostatitis, after six-month use of DATD pain reduction ranged
from 10.3 to 3.5, and prostate volume (mL) from 31.7 to 27.0. There were no changes in the control groups. Thus, TT is an effective
tool for urological conditions.